NewsCorporate ActionsIshita Pharmaceuticals Increases Stake in Ishita Drugs & Industries to 1.02%Ishita Pharmaceuticals Increases Stake in Ishita Drugs & Industries to 1.02%
Ishita Pharmaceuticals has increased its stake in Ishita Drugs & Industries to 1.02% through an additional acquisition of 560 shares worth Rs. 10.00 each on December 08, 2025. This follows earlier investments, bringing the total holding to 30,550 shares from the previous 29,990 shares, representing continued strategic interest between the related pharmaceutical companies.
*this image is generated using AI for illustrative purposes only.
Ishita Drugs & Industries , a pharmaceutical company, has witnessed continued investment from Ishita Pharmaceuticals, a related party, which has further increased its shareholding in the company. Following an earlier acquisition, Ishita Pharmaceuticals has made an additional purchase, demonstrating sustained interest in the target company.
Latest Transaction Details
In the most recent transaction dated December 08, 2025, Ishita Pharmaceuticals acquired an additional 560 shares of Ishita Drugs & Industries through open market purchase. Each share carries a face value of Rs. 10.00, representing a 0.02% increase in shareholding.
| Transaction Parameter: | Details |
|---|---|
| Shares Acquired: | 560 shares |
| Face Value per Share: | Rs. 10.00 |
| Transaction Date: | December 08, 2025 |
| Acquisition Method: | Open Market Purchase |
| Percentage Increase: | 0.02% |
Updated Shareholding Pattern
The cumulative effect of Ishita Pharmaceuticals' investments has resulted in a progressive increase in its stake in Ishita Drugs & Industries.
| Shareholding Status: | Before Latest Transaction | After Latest Transaction |
|---|---|---|
| Total Shares Held: | 29,990 shares | 30,550 shares |
| Voting Rights: | 1.00% | 1.02% |
| Share Capital Percentage: | 1.00% | 1.02% |
Company Capital Structure
The equity share capital of Ishita Drugs & Industries remains unchanged at Rs. 29,903,000.00, comprising 2,990,300 shares with a face value of Rs. 10.00 each. The recent acquisition does not impact the overall capital structure of the company.
Regulatory Compliance and Documentation
In accordance with SEBI regulations, specifically Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, both companies have filed the necessary disclosures. Ishita Drugs & Industries communicated the transaction details to BSE Limited on December 10, 2025, while Ishita Pharmaceuticals submitted its disclosure on December 09, 2025.
Market Implications
The progressive increase in shareholding by Ishita Pharmaceuticals, from an initial entry to now holding 1.02% of voting rights, indicates a strategic interest in Ishita Drugs & Industries. As related parties, this continued investment pattern suggests potential for enhanced collaboration and strategic alignment between the two pharmaceutical entities. The company is listed on BSE Limited under scrip code 524400.
Historical Stock Returns for Ishita Drugs & Indus
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.11% | +2.83% | +14.29% | -4.93% | -10.90% | +155.18% |
19
